Navigation Links
2 studies examine medical consequences of police use of force during restraint
Date:5/16/2009

Dr. Jared Strote at the University of Washington Medical Center led a group that examined the medical records of nearly 900 patients subdued by the Seattle Police Department with a Taser over a six-year period. Less than one percent required hospital admission for an injury related to the restraint incident. No deaths occurred, even when patients exhibited signs of excited delirium.

Meanwhile, a separate study led by Dr. Strote looked at every use of force by the Seattle Police Department in one year. Again, despite nearly 900 incidents, injuries related to the use of force were rare. Just over one percent required hospital admission for an injury related to the use of force by police. There were two deaths, both due to firearms.

The researchers conclude that injuries inflicted by police officers in the process of subduing suspects are relatively rare. Other related findings include a high incidence of drug and alcohol use and psychiatric history among those being restrained.


'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related medicine news :

1. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
2. Studies show LAM patients participate in clinical trials to help others, not themselves
3. Traumatic brain injury haunts children for years with variety of functional problems: Two studies
4. Review finds conflicts of interest in many cancer studies
5. Studies Report Use of USGI Medicals Incisionless Operating Platform(TM) (IOP) in Numerous Incisionless Surgical Procedures
6. Physicians Conduct Research Studies in Minutes, Not Months, at Montefiore Medical Center
7. Kessler Foundation Research Center Presented Two Studies on Post-stroke Spatial Neglect at American Academy of Neurology
8. Studies uncover high and often overlooked costs associated with epilepsy
9. Are we cherry picking participants for studies of antidepressants?
10. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
11. Pharos Innovations and Clients to Showcase Three Client Case Studies at Upcoming ATA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: